Sign up
Quantellect · Congress · Trade Detail
NYSE: PFEPfizer Inc
RepublicanHouse

K. Michael Conaway sold Pfizer Inc (NYSE: PFE)

K. Michael Conaway (R-TX), a U.S. Representative, has disclosed 8 trades in Pfizer Inc (PFE) since 2014, 4 purchases and 4 sales, worth an estimated $113K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a sale: K. Michael Conaway sold $1,001 - $15,000 of Pfizer Inc (NYSE: PFE) on April 18, 2019. Since that trade, PFE is down -4.98% against the S&P 500 up +179.21%, an outperformance of -184.20%.

Across these filings, K. Michael Conaway has been a balanced trader of PFE (a buy-to-sell ratio of 1.00). The most recent disclosed PFE transaction shown was dated July 1, 2020. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

PFE trades
8
Disclosed Vol
$113K
Buys
4
50%
Sells
4
50%
Buy / Sell
1.00
ratio
First → Last
2014–2020

K. Michael Conaway's PFE trades vs the price

PFE is down -4.98% since K. Michael Conaway sold on April 18, 2019, versus +179.21% for the S&P 500.

Performance since this trade

Price change since trade
-4.98%
S&P 500 change since trade
+179.21%
Outperformance vs S&P 500
-184.20%

All K. Michael Conaway PFE trades

TradedTypeSizeReturnEst. profit
July 1, 2020BUY$23.79+5.72%-$8K
April 18, 2019SELL$26.47-4.98%
December 21, 2018BUY$27.94-9.98%-$3K
November 21, 2018SELL$28.72-12.43%
February 26, 2018SELL$24.08+4.43%
September 12, 2016BUY$21.24+18.43%-$9K
February 9, 2015SELL$19.26+30.61%
September 18, 2014BUY$17.50+43.73%-$1K

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

K. Michael Conaway & PFE trading FAQ

Is it legal for K. Michael Conaway to trade Pfizer Inc (PFE) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Pfizer Inc (PFE), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did K. Michael Conaway sell PFE?

K. Michael Conaway disclosed a sale of $1,001 - $15,000 of Pfizer Inc (PFE) on April 18, 2019, according to public STOCK Act filings.

How has PFE performed since K. Michael Conaway's trade?

Since K. Michael Conaway sold PFE on April 18, 2019, the stock is down -4.98%, versus +179.21% for the S&P 500 over the same period, an outperformance of -184.20%.

How many times has K. Michael Conaway traded PFE?

K. Michael Conaway has disclosed 8 PFE trades since 2014 (4 purchases and 4 sales). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional PFE trades?

Quantellect tracks every disclosed congressional trade in Pfizer Inc (PFE) on the Pfizer Inc congressional trading page, which aggregates filings across all members of Congress.

K. Michael Conaway's PFE tradesAll congressional filings for Pfizer IncK. Michael Conaway's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.